In one paragraphArticle in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Siân JossiConserV Bioscience Ltd., Heyford Park Innovation Centre, Upper Heyford, Bicester OX25 5HD, UK.
Megan ColeConserV Bioscience Ltd., Heyford Park Innovation Centre, Upper Heyford, Bicester OX25 5HD, UK.ORCID 0000-0002-5154-5786 Yonca Keskek TurkVirus Host Interaction Team, Skin Research Centre, Hull York Medical School, University of York, York YO10 5DD, UK.ORCID 0000-0002-7955-086X Sam VerwimpLaboratory of Virus-Host Interactions and Therapeutic Applications, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Katholieke Universiteit (KU) Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-9957-0307 Katrien TrappeniersLaboratory of Virus-Host Interactions and Therapeutic Applications, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Katholieke Universiteit (KU) Leuven, 3000 Leuven, Belgium.
James LukDepartment of Biology, University of York, York YO10 5DD, UK.
Joshua X D AngDepartment of Biology, University of York, York YO10 5DD, UK.
Luke AlpheyDepartment of Biology, University of York, York YO10 5DD, UK.
Leen DelangLaboratory of Virus-Host Interactions and Therapeutic Applications, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Katholieke Universiteit (KU) Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-8874-675X Clive S McKimmieVirus Host Interaction Team, Skin Research Centre, Hull York Medical School, University of York, York YO10 5DD, UK.ORCID 0000-0002-7694-9509 Olga PleguezuelosConserV Bioscience Ltd., Heyford Park Innovation Centre, Upper Heyford, Bicester OX25 5HD, UK.ORCID 0000-0002-7099-5002 Funding
Biotechnology and Biological Sciences Research Council BB/X/002500/1Innovate UK 10083718Research Foundation - Flanders 11D5923NWellcome TrustWellcome Trust 300262/Z/23/Z
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AedesantibodiesarboviruschikungunyaCulexmosquito salivapeptidesT-cellvaccineVLPsZika
Identifiers
PMID42646740
PMCPMC13517861
What Socratic holds
Textmetadata
Read underepoch 390